Pregnancy

PACIFY LAUNCHES NEW, BEST-IN-CLASS MATERNAL HEALTH PLATFORM

Centered on personalizing the patient experience for expecting and new parents, Pacify is revolutionizing virtual care to drive better outcomes…

1 month ago

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management

VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March…

1 month ago

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond™, is designed to provide multiple levels of protection PRINCETON, N.J., March 3, 2025…

1 month ago

Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C

New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information…

2 months ago

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product…

2 months ago

Stork Club Launches the World’s First Comprehensive Care for Postpartum Depression to Help Employers Support Working Mothers

The solution features clinically proven digital diagnostics and therapy, delivering up to 20% immediate PPD symptom relief and 30-40% improvement…

2 months ago

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in…

2 months ago

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program’s Success and Growth Potential

OvaStem® Demonstrates Strong Long-Term Efficacy with No Safety Concerns, Backed by Pending Orphan Drug Designation for AlloStem®PHOENIX, Feb. 20, 2025…

2 months ago

Tech-Powered, Expert-Led, and Ready to Scale – SteelSky Ventures Invests in Posterity Health to Transform Fertility Care

ATLANTA, Feb. 19, 2025 /PRNewswire/ -- SteelSky Ventures, the world's leading women's health fund, has made a strategic investment in…

2 months ago

Arkstone Expands Maternal Care with NeoSure™: Now Integrating Breastfeeding Safety into OneChoice Reports

BOCA RATON, Fla., Feb. 13, 2025 /PRNewswire/ -- Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, proudly…

2 months ago